These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17373740)

  • 1. Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice.
    Ma XJ; Tian DY; Xu D; Yang DF; Zhu HF; Liang ZH; Zhang ZG
    World J Gastroenterol; 2007 Feb; 13(7):1060-6. PubMed ID: 17373740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
    Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of hepatitis B surface antigen-pulsed dendritic cells from immunosuppressed murine hepatitis B virus carrier: evaluation of immunogenicity of antigen-pulsed dendritic cells in vivo.
    Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
    Immunobiology; 2004; 209(7):551-7. PubMed ID: 15568619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Xie Y; Sun HX; Li D
    Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
    Stober D; Trobonjaca Z; Reimann J; Schirmbeck R
    Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
    Du DW; Jia ZS; Li GY; Zhou YY
    World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro].
    Xing LH; Wang FS; Zhu CL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):365-8. PubMed ID: 15340554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of dendritic cell-based immunization against HBV in transgenic mice.
    Jiang WZ; Fan Y; Liu X; Zhang YL; Wen JJ; Hao WL; Qian M
    Antiviral Res; 2008 Jan; 77(1):50-5. PubMed ID: 17897731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H; Han Q; Zhao H; Xu D; Zhang J
    Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
    Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
    Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
    Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
    World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo.
    Qiu J; Li GW; Sui YF; Song HP; Si SY; Ge W
    World J Gastroenterol; 2006 Jan; 12(3):473-8. PubMed ID: 16489653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.